Therapeutics News

It was just another day at school when sophomore Cole Villaflor and his classmates were asked to write on-demand essays in class. As he approached this seemingly easy assignment, his hands began to sweat, dampening the page.

Almirall has entered into an exclusive license agreement with Novo Nordisk to develop and commercialize NN-8828 for autoimmune and inflammatory dermatological diseases, according to a company press release.

Janus kinase inhibitor therapy in short durations did not significantly increase the risk for major adverse cardiovascular events or venous thromboembolism in patients with low cardiovascular risk profiles, according to a study.

Aurlumyn injection has been approved for the treatment of severe frostbite in adults to reduce the risk of finger or toe amputation, the FDA announced in a press release.

MIAMI BEACH, Fla. — Patients who are elderly or are poor candidates for surgery with nonmelanoma skin cancer would benefit from superficial radiation therapy, according to a speaker at South Beach Symposium.

MIAMI BEACH, Fla. — Pediatric dermatologists should be open with patients and families when discussing boxed warnings while emphasizing that the benefits outweigh the risks, according to a speaker here.

MIAMI BEACH, Fla. — Speakers at South Beach Symposium walked practitioners through the hair loss treatment journey from start to finish.

MIAMI BEACH, Fla. — The changing of seasons and geographical location may affect the utilization of photodynamic therapy for the treatment of actinic keratoses, according to a speaker at South Beach Symposium.

MIAMI BEACH, Fla. — Janus kinase inhibitors have a unique mechanism of action, giving them the potential to push the boundaries of efficacy in the treatment of inflammatory skin diseases, according to a speaker at South Beach Symposium.

The use of biologics to treat psoriasis does not affect antibody production after a patient has had a COVID infection or vaccination, according to a study.